Advertisement

The Prevalence of Retinal Vein Occlusion: Pooled Data from Population Studies from the United States, Europe, Asia, and Australia

Published:December 17, 2009DOI:https://doi.org/10.1016/j.ophtha.2009.07.017

      Objective

      To summarize the prevalence of retinal vein occlusion (RVO) from studies in the United States, Europe, Asia, and Australia.

      Design

      Pooled analysis using individual population-based data.

      Participants

      Individual participant data from population-based studies around the world that had ascertained RVO from fundus photographs.

      Methods

      Each study provided data on branch RVO and central RVO by age, sex, and ethnicity. Prevalence rates were directly age and sex standardized to the 2008 world population aged 30 years and older. Estimates were calculated by study and, after pooling, by ethnicity. Summary estimates included studies in which RVO was assessed from fundus photographs on ≥2 fields of both eyes.

      Main Outcome Measures

      Any RVO, CRVO, or BRVO.

      Results

      The combined pooled data contained 68,751 individuals from 15 studies, with participants' ages ranging from 30 to 101 years. In analyses of 11 studies that assessed ≥2 fundus fields of both eyes (n=49,869), the age- and sex-standardized prevalence was 5.20 per 1000 (confidence interval [CI], 4.40–5.99) for any RVO, 4.42 per 1000 (CI, 3.65–5.19) for BRVO, and 0.80 per 1000 (CI, 0.61–0.99) for CRVO. Prevalence varied by race/ethnicity and increased with age, but did not differ by gender. The age- and sex-standardized prevalence of any RVO was 3.7 per 1000 (CI, 2.8–4.6) in whites (5 studies), 3.9 per 1000 (CI, 1.8–6.0) in blacks (1 study), 5.7 per 1000 (CI, 4.5–6.8) in Asians (6 studies), and 6.9 per 1000 (CI, 5.7–8.3) in Hispanics (3 studies). Prevalence for CRVO was lower than BRVO in all ethnic populations. On the basis of these data, an estimated 16.4 million (CI, 13.9–18.9) adults are affected by RVO, with 2.5 million (CI, 1.9–3.1) affected by CRVO and 13.9 million (CI, 11.5–16.4) affected by BRVO. Study limitations include non-uniform sampling frames in identifying study participants and in acquisition and grading of RVO data.

      Conclusions

      Our study provides summary data on the prevalence of RVO and suggests that approximately 16 million people may have this condition. Research on preventive and treatment strategies for this sight-threatening eye disease is needed.

      Financial Disclosure(s)

      Proprietary or commercial disclosure may be found after the references.
      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to Ophthalmology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Liebreich R.
        Ophthalmoskopische Notizen: Ueber die Farbe des Augengrundes.
        Albrecht Von Graefes Arch Ophthalmol. 1855; 1: 333-343
        • Klein R.
        • Klein B.E.
        • Moss S.E.
        • Meuer S.M.
        The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study.
        Trans Am Ophthalmol Soc. 2000; 98: 133-141
        • Mitchell P.
        • Smith W.
        • Chang A.
        Prevalence and associations of retinal vein occlusion in Australia: the Blue Mountains Eye Study.
        Arch Ophthalmol. 1996; 114: 1243-1247
        • Wong T.Y.
        • Larsen E.K.
        • Klein R.
        • et al.
        Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: the Atherosclerosis Risk in Communities & Cardiovascular Health studies.
        Ophthalmology. 2005; 112: 540-547
        • Liu W.
        • Xu L.
        • Jonas J.B.
        Vein occlusion in Chinese subjects [letter].
        Ophthalmology. 2007; 114: 1795-1796
        • Cheung N.
        • Klein R.
        • Wang J.J.
        • et al.
        Traditional and novel cardiovascular risk factors for retinal vein occlusion: the multiethnic study of atherosclerosis.
        Invest Ophthalmol Vis Sci. 2008; 49: 4297-4302
        • Lim L.L.
        • Cheung N.
        • Wang J.J.
        • et al.
        Prevalence and risk factors of retinal vein occlusion in an Asian population.
        Br J Ophthalmol. 2008; 92: 1316-1319
        • Hayreh S.S.
        • Zimmerman B.
        • McCarthy M.J.
        • Podhajsky P.
        Systemic diseases associated with various types of retinal vein occlusion.
        Am J Ophthalmol. 2001; 131: 61-77
        • O'Mahoney P.R.
        • Wong D.T.
        • Ray J.G.
        Retinal vein occlusion and traditional risk factors for atherosclerosis.
        Arch Ophthalmol. 2008; 126: 692-699
        • Hayreh S.S.
        Prevalent misconceptions about acute retinal vascular occlusive disorders.
        Prog Retin Eye Res. 2005; 24: 493-519
        • McIntosh R.L.
        • Mohamed Q.
        • Saw S.M.
        • Wong T.Y.
        Interventions for branch retinal vein occlusion: an evidence-based systemic review.
        Ophthalmology. 2007; 114: 835-854
        • Mohamed Q.
        • McIntosh R.L.
        • Saw S.M.
        • Wong T.Y.
        Interventions for central retinal vein occlusion: an evidence-based systematic review.
        Ophthalmology. 2007; 114 (524): 507-519
        • de Weerd M.
        • Greving J.P.
        • de Jong A.W.
        • et al.
        Prevalence of asymptomatic carotid artery stenosis according to age and sex: systematic review and metaregression analysis.
        Stroke. 2009; 40: 1105-1113
        • US Census Bureau
        International Data Base. Total Midyear Population for the World: 1950-2050.
        (Accessed July 7, 2009)
        • Keyfitz N.
        3. Sampling variance of standardized mortality rates.
        Hum Biol. 1966; 38: 309-317
        • Verougstraete C.
        Is change of the vessel wall a risk factor for venous thrombosis [letter]?.
        Lancet. 1999; 353: 2158
        • Wong T.Y.
        • Mitchell P.
        The eye in hypertension.
        Lancet. 2007; 369: 425-435
        • Leenen F.H.
        • Dumais J.
        • McInnis N.H.
        • et al.
        Results of the Ontario survey on the prevalence and control of hypertension.
        CMAJ. 2008; 178: 1441-1449
        • Read J.G.
        • Gorman B.K.
        Racial/ethnic differences in hypertension and depression among US adult women.
        Ethn Dis. 2007; 17: 389-396
        • Giles T.
        • Aranda Jr, J.M.
        • Suh D.C.
        • et al.
        Ethnic/racial variations in blood pressure awareness, treatment, and control.
        J Clin Hypertens (Greenwich). 2007; 9: 345-354
        • Ostchega Y.
        • Hughes J.P.
        • Wright J.D.
        • et al.
        Are demographic characteristics, health care access and utilization, and comorbid conditions associated with hypertension among US adults?.
        Am J Hypertens. 2008; 21: 159-165
        • Wong T.Y.
        • Hyman L.
        Population-based studies in ophthalmology.
        Am J Ophthalmol. 2008; 146: 656-663
        • ARIC Investigators
        The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives.
        Am J Epidemiol. 1989; 129: 687-702
        • Xu L.
        • Cui T.
        • Zhang S.
        • et al.
        Prevalence and risk factors of lens opacities in urban and rural Chinese in Beijing.
        Ophthalmology. 2006; 113: 747-755
        • Mitchell P.
        • Smith W.
        • Attebo K.
        • Wang J.J.
        Prevalence of age-related maculopathy in Australia: the Blue Mountains Eye Study.
        Ophthalmology. 1995; 102: 1450-1460
        • Fried L.P.
        • Borhani N.O.
        • Enright P.
        • et al.
        The Cardiovascular Health Study: design and rationale.
        Ann Epidemiol. 1991; 1: 263-276
        • Augood C.
        • Fletcher A.
        • Bentham G.
        • et al.
        Methods for a population-based study of the prevalence of and risk factors for age-related maculopathy and macular degeneration in elderly European populations: the EUREYE Study.
        Ophthalmic Epidemiol. 2004; 11: 117-129
        • Kawasaki R.
        • Wang J.J.
        • Rochtchina E.
        • et al.
        Cardiovascular risk factors and retinal microvascular signs in an adult Japanese population: the Funagata Study.
        Ophthalmology. 2006; 113: 1378-1384
        • Liang Y.B.
        • Friedman D.S.
        • Wong T.Y.
        • et al.
        • Handan Eye Study Group
        Prevalence and causes of low vision and blindness in a rural Chinese adult population: the Handan Eye Study.
        Ophthalmology. 2008; 115: 1965-1972
        • Wang F.H.
        • Liang Y.B.
        • Zhang F.
        • et al.
        Prevalence of diabetic retinopathy in rural China: the Handan Eye Study.
        Ophthalmology. 2009; 116: 461-467
        • Oshima Y.
        • Ishibashi T.
        • Murata T.
        • et al.
        Prevalence of age related maculopathy in a representative Japanese population: the Hisayama study.
        Br J Ophthalmol. 2001; 85: 1153-1157
        • Varma R.
        • Paz S.H.
        • Azen S.P.
        • et al.
        • Los Angeles Latino Eye Study Group
        The Los Angeles Latino Eye Study: design, methods, and baseline data.
        Ophthalmology. 2004; 111: 1121-1131
        • Klein R.
        • Klein B.E.
        • Knudtson M.D.
        • et al.
        Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis.
        Ophthalmology. 2006; 113: 373-380
        • West S.K.
        • Klein R.
        • Rodriguez J.
        • et al.
        Diabetes and diabetic retinopathy in a Mexican-American population: Proyecto VER.
        Diabetes Care. 2001; 24: 1204-1209
        • Hofman A.
        • Breteler M.M.
        • van Duijn C.M.
        • et al.
        The Rotterdam Study: objectives and design update.
        Eur J Epidemiol. 2007; 22: 819-829
        • van Leeuwen R.
        • Klaver C.C.
        • Vingerling J.R.
        • et al.
        The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study.
        Arch Ophthalmol. 2003; 121: 519-526
        • Chen S.J.
        • Cheng C.Y.
        • Peng K.L.
        • et al.
        Prevalence and associated risk factors of age-related macular degeneration in an elderly Chinese population in Taiwan: the Shihpai Eye Study.
        Invest Ophthalmol Vis Sci. 2008; 49: 3126-3133
        • Foong A.W.
        • Saw S.M.
        • Loo J.L.
        • et al.
        Rationale and methodology for a population-based study of eye diseases in Malay people: the Singapore Malay Eye Study (SiMES).
        Ophthalmic Epidemiol. 2007; 14: 25-35